For: | Pan L, Fang J, Chen MY, Zhai ST, Zhang B, Jiang ZY, Juengpanich S, Wang YF, Cai XJ. Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma. World J Gastroenterol 2020; 26(8): 789-803 [PMID: 32148377 DOI: 10.3748/wjg.v26.i8.789] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i8/789.htm |
Number | Citing Articles |
1 |
Hui Zhang, Xu Zhang, Weiguo Xu, Jian Wang. TMC5 is Highly Expressed in Human Cancers and Corelates to Prognosis and Immune Cell Infiltration: A Comprehensive Bioinformatics Analysis. Frontiers in Molecular Biosciences 2022; 8 doi: 10.3389/fmolb.2021.810864
|
2 |
Liang Zeng, Xiao-Yun Liu, Lei Miao, Kai Chen, Hui Xu, Liang-Jun Qin, Meng Li, Kai Liu, Jiahao Feng, Hai-Yun Wang. Risk model based on minichromosome maintenance 2 using objective assessment for predicting survival of neuroblastoma. iScience 2023; 26(2): 105974 doi: 10.1016/j.isci.2023.105974
|
3 |
Congxue Hu, Yongqi Lei, Xinyang Liu, Xingxin Yu, Zhida Geng, Yu Liu, Liyu Yang, Xuehong Tie, Wenzhe Zhou, Xia Li, Yunpeng Zhang, Yingjian Liang. Dissecting microenvironment in cystadenomas and hepatic cysts based on single nucleus RNA-sequencing data. Computers in Biology and Medicine 2024; 176: 108541 doi: 10.1016/j.compbiomed.2024.108541
|
4 |
Xin Cheng, Yucheng Cao, Xiaowei Wang, Lin Cheng, Yaqiong Liu, Jun Lei, Weijun Peng, Dazun Shi, Xue-Li Zhang. Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/5254911
|
5 |
Xiang-Yu Gan, Jian-Di Li, Gang Chen, Rong-Quan He, Jia-Yuan Luo, Jing-Jing Zeng, Zi-Xuan Yang, Yu-Xuan Yao, Jun-Jie Zhu, Jian-Jun Li, Dan-Ming Wei. Role of Up-Regulated Transmembrane Channel-Like Protein 5 in Pancreatic Adenocarcinoma. Digestive Diseases and Sciences 2023; 68(5): 1894 doi: 10.1007/s10620-022-07771-7
|
6 |
CHUAN TIAN, MUBALAKE ABUDOUREYIMU, XINRONG LIN, HAO ZHOU, XIAOYUAN CHU, RUI WANG. Immune prognostic implications of PSMD14 and its associated genes signatures in hepatocellular carcinoma. BIOCELL 2021; 45(6): 1527 doi: 10.32604/biocell.2021.016203
|
7 |
Noémi Sándor, Andrea E. Schneider, Alexandra T. Matola, Veronika H. Barbai, Dániel Bencze, Hani Hashim Hammad, Alexandra Papp, Dorottya Kövesdi, Barbara Uzonyi, Mihály Józsi. The human factor H protein family – an update. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1135490
|
8 |
Astha Malik, Unmesha Thanekar, Surya Amarachintha, Reena Mourya, Shreya Nalluri, Alexander Bondoc, Pranavkumar Shivakumar. “Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.627701
|
9 |
Tao Ouyang, Xuefeng Kan, Chuansheng Zheng. Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.898964
|
10 |
Haoyu Wang, Wenjie Shi, Jing Lu, Yuan Liu, Wei Zhou, Zekun Yu, Shengying Qin, Junwei Fan. HCC: RNA-Sequencing in Cirrhosis. Biomolecules 2023; 13(1): 141 doi: 10.3390/biom13010141
|
11 |
Yongjun Guan, Man Li, Zhendong Qiu, Junhui Xu, Yichao Zhang, Ning Hu, Xuanzhe Zhang, Wenyi Guo, Jingping Yuan, Qiao Shi, Weixing Wang. Comprehensive analysis of DOK family genes expression, immune characteristics, and drug sensitivity in human tumors. Journal of Advanced Research 2022; 36: 73 doi: 10.1016/j.jare.2021.06.008
|
12 |
Shitao Jiang, Junwei Zhang, Jin Bian, Lei Zhang, Yiyao Xu, Haitao Zhao, Xinting Sang, Xin Lu. Novel nomograms based on immune and stromal scores for predicting the disease‐free and overall survival of patients with hepatocellular carcinoma undergoing radical surgery. Journal of Surgical Oncology 2020; 122(8): 1569 doi: 10.1002/jso.26197
|
13 |
Lihua Yu, Xiaoli Liu, Xinhui Wang, Huiwen Yan, Qing Pu, Yuqing Xie, Juan Du, Zhiyun Yang. Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.940551
|
14 |
Yifei Dai, Weijie Qiang, Kequan Lin, Yu Gui, Xun Lan, Dong Wang. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma. Cancer Immunology, Immunotherapy 2021; 70(4): 967 doi: 10.1007/s00262-020-02743-0
|
15 |
Shenghua Pan, Tingting Tang, Yanke Wu, Liang Zhang, Zekai Song, Sisi Yu. Identification and Validation of Immune-Related Prognostic Genes in the Tumor Microenvironment of Colon Adenocarcinoma. Frontiers in Genetics 2022; 12 doi: 10.3389/fgene.2021.778153
|
16 |
Fengyong Luo, Zhihuai Wang, Shuai Chen, Zhenbo Luo, Gaochao Wang, Haojun Yang, Liming Tang, Nagarajan Raju. DOK5 as a Prognostic Biomarker of Gastric Cancer Immunoinvasion: A Bioinformatics Analysis. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/9914778
|
17 |
Deyi Sun, Jiqian Xu, Wanying Zhang, Chaoying Song, Chenggang Gao, Yajun He, You Shang. Negative regulator NLRC3: Its potential role and regulatory mechanism in immune response and immune-related diseases. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1012459
|
18 |
Zhihuai Wang, Adeel Ur Rehman, Xihu Qin, Chunfu Zhu, Siyuan Wu, Ihtisham Bukhari. PI3K/AKT/mTOR Pathway-Associated Genes Reveal a Putative Prognostic Signature Correlated with Immune Infiltration in Hepatocellular Carcinoma. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/7545666
|
19 |
Xiuzhi Zhang, Xiaoli Liu, Keke Zhu, Xue Zhang, Ningning Li, Tao Sun, Shasha Fan, Liping Dai, Jinzhong Zhang. CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02820-7
|
20 |
Wenbin Tang, Zhiyuan Shi, Yasheng Zhu, Zhengda Shan, Aimin Jiang, Anbang Wang, Ming Chen, Yi Bao, Guanqun Ju, Weidong Xu, Junkai Wang. Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-38914-z
|
21 |
Yuchen Liu, Zhechen Wu, Ziyue Fu, Yanxun Han, Jianpeng Wang, Yanqiang Zhang, Bingyu Liang, Ye Tao, Yuchen Zhang, Chuanlu Shen, Yidan Xu, Siyue Yin, Bangjie Chen, Yehai Liu, Haifeng Pan, Zhang Liang, Kaile Wu. A predictive model of immune infiltration and prognosis of head and neck squamous cell carcinoma based on cell adhesion-related genes: including molecular biological validation. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1190678
|
22 |
Zhiyu Chen, Jing Su, Ningning You, Hong Lin, Shanshan Lin, Zhenjiang Zhang, Yi Chen. A novel model based on ubiquitination-related gene to predict prognosis and immunotherapy response in hepatocellular carcinoma. Heliyon 2024; 10(8): e29387 doi: 10.1016/j.heliyon.2024.e29387
|
23 |
Shixin Xiang, Jing Li, Jing Shen, Yueshui Zhao, Xu Wu, Mingxing Li, Xiao Yang, Parham Jabbarzadeh Kaboli, Fukuan Du, Yuan Zheng, Qinglian Wen, Chi Hin Cho, Tao Yi, Zhangang Xiao. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.653836
|
24 |
Ning Xu, Xiangyu Meng, Hongyu Chu, Zhaoying Yang, Yan Jiao, Youjun Li. The prognostic significance of KLRB1 and its further association with immune cells in breast cancer. PeerJ 2023; 11: e15654 doi: 10.7717/peerj.15654
|